pretickt

Why is REGN stock moving?

Regeneron Pharmaceuticals, Inc. · end-of-day data as of Oct 16, 2026

Regeneron Pharmaceuticals, Inc.
REGN · $81.41B
$790.74+20.7%last 60 sessions · close Oct 16, 2026
$566.26$852.0352 weeks
Buy · 29 analystsPT $859.53 +8.7%
  • P/E vs own+18.0%
  • P/E vs sector-30.5%
  • Target upside+8.7%
  • Off 52w high-7.2%
  • Insiders-$6.51M
  • FCF yield+4.3%
  • Earnings in14d
  • Trendsideways
  • Sector▲ +16.0%
  • RSI57
  • MA20×50Death 10d ago
  • Volume0.9x
  • Support-2.2%
  • Resistance+1.5%

The move, split

Regeneron Pharmaceuticals, Inc. (REGN) fell 0.7% on Oct 16, 2026.

The market (SPY) fell 1.1%; Healthcare stocks fell 0.7%. Most of the move came from the market as a whole.

Market (SPY)-1.1%
Healthcare sector+0.4%
REGN specific0.0%

2 stories on the day (30-day average 1.4).

Market = SPY. Sector = equal-weight average of the tracked companies in the same sector, net of the market.

Context

  • News
  • Volume0.9x
  • Off 52w high-7.2%
  • Sector▲ +16.0%
  • Earnings in14d

Latest news

Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.